HomeMy WebLinkAboutItem #3 Opioid Participation AgreementsJoey Bowers
Subject: DEADLINE REMINDER June 4, 2026: Six Remnant Defendants Settlement - CL -2017330
To: Chubbuck city, ID
Reference Number: CL -2017330
Deadline: June 4, 2026
You are receiving this notice because your subdivision has NOT yet signed and returned
a participation agreement for the National Opioid Settlement with the Six Remnant
Defendants: Associated Pharmacies, Inc. (and American Associated Pharmacies); I M
Smith Corporation; Louisiana Wholesale Drug Company, Inc.; Morris and Dickson Co.;
North Carolina Mutual Wholesale Drug Company, Inc.; and United Natural Foods, Inc.
(including its subsidiaries SuperValu and Advantage Logistics) (each individually, a
"Remnant Defendant," and, collectively, the "Six Remnant Defendants"). As a reminder,
the deadline to participate is June 4, 2026.
The participation form was sent via DocuSign and contains the following information:
Address of Sender:
Subject of Email: NEW NATIONAL OPIOID SETTLEMENT NOTICE - Six Remnant
Defendants - CL -2017330
Please check your inbox, spam folder, and junk folder for the above email. You may
contact opioidsparticipation@rubris.com to request your participation form to be resent.
Please include the name, state, and reference ID of your subdivision in the body of the
email and use the subject line Settlement Participation Form - Chubbuck city, ID - CL -
2017330.
YOU MUST PARTICIPATE IN THE SIX REMNANT DEFENDANTS SETTLEMENT BY
RETURNING YOUR PARTICIPATION FORM IN ORDER TO RECEIVE THE BENEFITS
OF THE SIX REMNANT DEFENDANTS SETTLEMENT.
How to return signed forms:
There are three methods for returning the executed Combined Subdivision Participation
and Release Form to the Notice and Claims Administrator:
(1) Electronic Signature via DocuSign: Executing the Combined Subdivision Participation
and Release Form electronically through DocuSign will return the signed form to the
Notice and Claims Administrator and associate your form with your entity's records.
Electronic signature is the most efficient method for returning the Combined Subdivision
Participation and Release Form, allowing for more timely participation and the potential
to meet higher settlement payment thresholds, and is therefore strongly encouraged.
(2) Manual Signature returned via Rubris Platform Portal: If your entity is unable to
1
return an executed Combined Subdivision Participation and Release Form using
DocuSign, the signed Combined Subdivision Participation and Release Form may be
submitted via the Rubris Platform Portal. Please utilize the link within the New National
Opioid Settlement Notice email in order to upload your entity's Combined Subdivision
Participation and Release Form directly to the Rubris Platform Portal.
(3) Manual Signature returned via electronic mail: If your entity is unable to return an
executed Combined Subdivision Participation and Release Form using DocuSign, the
signed Combined Subdivision Participation and Release Form may be returned via
electronic mail to opioidsparticipation@rubris.com. Please include the name, state, and
reference ID of your entity in the body of the email and use the subject line Combined
Subdivision Participation and Release Form - Chubbuck city, ID - CL-2017330.
Detailed instructions on how to sign and return the Participation Form, including
changing the authorized signer, can be found at
https://nationalopioidsettlement.com/remnant-settlements/. You may also contact
opioidsparticipation@rubris.com.
If you have any questions about executing the Combined Subdivision Participation and
Release Form, please contact your counsel or the Notice and Claims Administrator at
opioidsparticipation@rubris.com.
Thank you,
National Opioids Settlements Notice and Claims Administrator for Six Remnant
Defendants
The Notice and Claims Administrator is retained to provide the Settlement Notice
required by the Settlement Agreement referenced above and to manage the collection of
Subdivision Settlement Participation Forms.
CAUTION: This email originated from outside the organization. Do not click links or open attachments
unless you recognize the sender and know the content is safe.
2
National Opioids Settlements: Six Remnant Defendants
Notice and Claims Administrator
opioidsparticipation@rubris.com
To: Chubbuck city, ID
Reference Number: CL -2017330
THIS SETTLEMENT OVERVIEW CONTAINS IMPORTANT INFORMATION ABOUT
THE SIX REMNANT DEFENDANTS NATIONAL OPIOID SETTLEMENT
SIX REMNANT DEFENDANTS SETTLEMENT OVERVIEW
A new national opioid settlement has been reached with six regional distributors/dispenser
defendants (Remnant Defendants Settlement): Associated Pharmacies, Inc (and
American Associated Pharmacies); J M Smith Corporation; Louisiana Wholesale Drug
Company, Inc.; Morris and Dickson Co.; North Carolina Mutual Wholesale Drug
Company, Inc.; and United Natural Foods, Inc. (including its subsidiaries SuperValu and
Advantage Logistics) (Six Remnant Defendants). There is one settlement agreement
covering the combined settlement with the Six Remnant Defendants.
If effectuated, the proposed Remnant Defendants Settlement will result in the the Six
Remnant Defendants paying a combined $97,625,000.00 in cash for purposes of abating
the opioid epidemic. An Eligible Entity's participation in the Remnant Defendants
Settlement, the Settlement will result in a one-time settlement payment to each Eligible
Entity. The Settlement funds must be used for the Core Strategies and Approved Uses set
forth in Exhibit D of the Remnant Defendant Settlement Agreement.
The Remnant Defendants Settlement does not include State Attorneys General or any
amount allocated to a State. Rather, this Settlement will be distributed only and directly to
any Eligible Entity that participates by signing and returning the Combined Subdivision
Participation and Release Form by the deadline.
The allocation to participating entities will be calculated using the national Denver model
but removing from the equation any amount that the Denver model would allocate to a
State Attorney General or a State allocation. Specifically, the interstate allocation formula
will be used to calculate what amount should go to all the subdivisions in each state and
then apply the intrastate allocation as between all subdivisions who are either a litigating
subdivision or a non -litigating subdivision with a population of 30,000 or more. Using that
methodology, a national pro -rata percentage was created. That allocation percentage of
participation is reflected in Exhibit E of the Remnant Defendant Settlement Agreement.
0 0
182891755.1 0
Eligible Entities must decide whether to participate by Thursday, June 4, 2026.
WHO IS RUBRIS INC. AND WHAT IS THE NOTICE AND CLAIMS
ADMINISTRATOR?
The Settlement provides that a Notice and Claims Administrator will provide notice and
manage the collection of participation forms. Rubris, Inc. is the Notice and Claims
Administrator for this new Settlement and was also retained for the prior national opioid
settlements.
WHY IS YOUR ENTITY RECEIVING THIS NOTICE?
Your entity is eligible to participate in this Settlement. This Notice is also sent directly to
counsel for each Eligible Entity if the Notice and Claims Administrator has their
information. If you are represented by an attorney with respect to opioid claims, please
contact them.
WHERE CAN YOU FIND MORE INFORMATION?
Detailed information about the Settlement may be found at:
httas://nationalor)ioidsettlement.com
You are encouraged to review the Settlement Agreement terms and discuss the terms
and benefits with your counsel. Each Eligible Entity will need to decide whether to
participate in the proposed Settlement, and entities are encouraged to work through this
process before the Monday, June 4, 2026, deadline.
HOW DO YOU PARTICIPATE IN THE SETTLEMENT?
The Settlement requires that each Eligible Entity take affirmative steps to "opt in" to the
Settlement. You will receive the Combined Subdivision Participation and Release Form
via DocuSign along with instructions from the Implementation Administrator. In order to
participate in this Settlement, a person with authority must sign and return the required
Combined Subdivision Participation and Release Form. DocuSign remains the preferred
method of submission of the needed form.
The participation rate will be used to determine whether participation for each Remnant
Defendant is sufficient to move forward. If the Settlement moves forward, your release will
become effective as to that Remnant Defendant. If the settlement as to any Remnant
Defendant does not move forward, the release as to that Remnant Defendant will not
become effective.
Please add the following email addresses to your "safe" list so emails do not go to spam /
funk folders: dse na3gdocus4gn.net and opioidsparticipationgg rubris.com. Please
monitor vour email for the Particiaation Form and instructions.
0 0
182891755.1 0
All required documentation must be signed and returned on or before Thursday, June 4,
2026. Upon effectuation of the Remnant Defendants Settlement, each Eligible Entity will
be provided with a link to a portal where you will enter contact and payment information
to receive settlement funds.
182891755.1